New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Does your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which ...